WPWiryawan Permadi

Wiryawan Permadi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wiryawan Permadi has a total of 42 co-authors. Here are the top co-authors by number of shared publications:

  • Anita Rachmawati

    Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Hasan Sadikin General Teaching Hospital, Faculty of Medicine, Padjadjaran University, Bandung, West Java, Indonesia

    2 shared publications
  • Dian Tjahyadi

    Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Hasan Sadikin General Teaching Hospital, Faculty of Medicine, Padjadjaran University, Bandung, West Java, Indonesia

    2 shared publications
  • Ruswana Anwar

    Department of Obstetrics and Gynecology, Hasan Sadikin General Teaching Hospital, Faculty of Medicine, Padjadjaran University, Bandung, West Java, Indonesia

    2 shared publications
  • Tono Djuwantono

    Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Padjadjaran, Jatinangor 45363, Indonesia

    2 shared publications
  • Adhi Pribadi

    Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Padjadjaran/Dr. Hasan Sadikin General Hospital, Bandung

    1 shared publication
  • Adi Setyawan Prianto

    1 shared publication

Latest Publications

  • Open Access

    The Association of Methylenetetrahydrofolate Reductase C677T Polymorphism, Serum 5-Methyltetrahydrofolate, and Homocysteine Levels with Adenomyosis: A Cross-Sectional Study in an Indonesian Population

    by Martin Hermawan, Dian Tjahyadi, Anita Rachmawati, Wiryawan Permadi, Hanom Husni Syam, Anom Suardika, Ruswana Anwar

    Purpose: Adenomyosis is a complex uterine condition, with emerging evidence indicating epigenetic alterations play a role in its pathogenesis. The methylenetetrahydrofolate reductase (MTHFR) gene polymorphism C677T may reduce enzyme activity, affecting DNA methylation and increasing adenomyosis risk. This study compares the MTHFR C677T polymorphism, 5-methyltetrahydrofolate (5-MTHF) levels, and homocysteine levels in patients with adenomyosis. Patients and Methods: This cross-sectional study involved 61 subjects: 31 patients with adenomyosis and 30 patients as controls. The MTHFR C677T polymorphism was analyzed using PCR-RFLP, serum 5-MTHF and homocysteine levels were measured using ELISA. Statistical analyses were performed to compare genotype distributions and metabolite levels between groups and within the adenomyosis group based on genotype. Results: The study found a significant difference in the distribution of the MTHFR C677T genotype between adenomyosis and control groups (p=0.018), with a higher prevalence of the CT genotype in the adenomyosis group (35.5% vs 10.0%). The frequency of the T allele was also elevated in the adenomyosis group (17.7% vs 5.0%; p=0.027). Serum 5-MTHF levels were notably lower in the adenomyosis group (23.92 ± 4.599 nmol/l) compared to controls (32.45 ± 3.019 nmol/l; p< 0.0001), while homocysteine levels were significantly higher in the adenomyosis group (12.87 ± 8.916 µmol/L vs 8.61 ± 1.352 µmol/L; p=0.019). Further analysis of MTHFR genotypes indicated lower 5-MTHF levels in both CC and CT genotypes among the adenomyosis group compared to controls (p< 0.0001). Homocysteine levels showed no significant difference across genotypes (p=0.074), though there was a trend towards higher levels in the adenomyosis group. Conclusion: This study demonstrates a significant difference in the distribution of the MTHFR C677T polymorphism, lower 5-MTHF levels, and higher homocysteine levels in patients with adenomyosis compared to controls. Lower 5-MTHF levels were also shown to be strongly linked with the heterozygous C677T polymorphism in the adenomyosis group.


  • Open Access

    Isolated Premature Menarche in a 17-Month-Old: A Case Report

    by Dewi Rani Pelitawati, Artha Falentin Putri Susilo, Anita Rachmawati, Wiryawan Permadi, Putri Nadhira Adinda Adriansyah, Nabila Chantikarizky Hasanah

    BACKGROUND Vaginal bleeding in prepubertal girls is an uncommon finding and should always prompt thorough evaluation. Puberty is a complex physiological process resulting from maturation of the hypothalamic-pituitary-gonadal axis. Precocious puberty is defined as the early onset of secondary sexual characteristics before the age of 8 years in girls. The incidence ranges from 1 in 5000 to 1 in 10 000 girls worldwide. In contrast, isolated premature menarche is a rare and benign condition characterized by vaginal bleeding without other signs of pubertal activation and remains a diagnosis of exclusion. CASE REPORT We report a 17-month-old female infant who presented with recurrent vaginal bleeding every month over the 3 months prior to admission. Physical examination showed normal external genitalia, with no signs of inflammation, trauma, foreign body, or sexual abuse. There were no secondary sexual characteristics, and growth parameters were appropriate for age. Laboratory examination revealed prepubertal basal gonadotropin levels, normal hormonal levels, normal thyroid function tests, and bone age consistent with chronological age. Platelet function testing showed hyperaggregation, considered a transient and incidental finding. Pelvic ultrasonography demonstrated the size of the uterus was consistent with the age of puberty. After exclusion of local, endocrine, and systemic causes, a diagnosis of isolated premature menarche was established. CONCLUSIONS Menstrual-like vaginal bleeding in prepubertal girls requires systematic and comprehensive examination to differentiate isolated premature menarche from other diseases. Recognition of this benign entity is important to avoid unnecessary interventions and ascertain appropriate follow-up.

  • Open Access

    Kallmann Syndrome in a 30‐Year‐Old Female With Primary Infertility: A Case Report

    by Arry Soryadharma, Mulyanusa Amarullah Ritonga, Wiryawan Permadi

    Kallmann syndrome (KS) is a rare genetic disorder characterized by hypogonadotropic hypogonadism and anosmia. This case report highlights a 30‐year‐old woman with KS who presented with secondary amenorrhea and uterine hypoplasia after repeated use of combined oral contraceptives (COCs). She had a 5‐year history of primary infertility, hyposmia, and primary amenorrhea. Initially, it was unclear whether her amenorrhea was primary or secondary. However, after interviewing her mother, it was determined that she had primary amenorrhea. Physical examination showed a normal female appearance, with Tanner Stage T1 for pubic hair and T3 for breasts, possibly due to obesity. Hormonal tests revealed low levels of FSH, LH, and estrogen. An MRI of the head demonstrated olfactory bulb aplasia, supporting the clinical diagnosis of KS. Karyotyping confirmed a 46,XX chromosome pattern. The diagnosis of KS was established, and the patient was referred for fertility counseling and ovarian stimulation. KS is typically diagnosed during puberty due to primary amenorrhea, and distinguishing it from other genetic disorders requires karyotyping. This patient′s condition was exacerbated by the repeated use of E‐P pills, which delayed proper diagnosis. Fertility treatment options, including ovarian stimulation with gonadotropins and ovulation induction, were recommended to help the patient conceive. This report emphasizes the importance of careful consideration before administering repeated hormonal treatments and underscores the potential for fertility treatments in females with KS. It highlights the need for clinicians to be vigilant in diagnosing and managing KS, especially in patients with hypogonadotropic hypogonadism and anosmia.

  • Open Access

    Correlation of Histological Type, Stage, Age, and Prognosis in Uterine Cervical Cancer at Margono Soekardjo Hospital Purwokerto from January – December 2024

    by Eka Maranatha Tambunan, Wiryawan Permadi, Aditiyono Aditiyono, Grazielle Grazielle

    Objective: To evaluate the correlation of histological subtype, stage, age, and prognosis in cervical cancer patients treated at Prof. Dr. Margono Soekarjo Hospital, Purwokerto.Methods: This is a retrospective descriptive cohort study conducted using medical records. Data on cervical cancer staging, age, and histopathological subtype were collected from all patients meeting the inclusion criteria. Statistical analysis was performed, and associations were examined using chi-square tests. The data used in the study were obtained from the medical records of patients at the research site from January to December 2024.Result: Of 582 patients identified, 245 met the inclusion criteria. Squamous cell carcinoma (SCC) accounted for 147 cases, and adenocarcinoma (AC) for 98. Most patients were aged >50 years old and diagnosed at stage II. SCC was most common at stage II, while AC was most frequently found at stage III. Statistical analysis revealed a significant but weak association between age, stage, prognosis, and histological subtype.Conclusion: There was a significant weak correlation of histological subtype and age, stage, and prognosis in cervical cancer.Korelasi Tipe Histologis, Stadium, Usia, dan Prognosis pada Kanker Uterin Serviks di Rumah Sakit Margono Soekardjo pada Januari – Desember 2024AbstrakTujuan: Penelitian ini bertujuan untuk mengetahui korelasi antara subtipe histologis, stadium, usia, dan prognosis kanker serviks uteri pada pasien yang diobati di RSUD Prof. Dr. Soekarjo Margono, Purwokerto, dalam rentang waktu Januari – Desember 2024Metode: Studi ini merupakan studi retrospektif deskriptif kohort dengan data dari rekam medis. Data yang diambil adalah stadium kanker, usia, dan subtipe histopatologis dan didapatkan dari semua pasien yang memenuhi kriteria inklusi. Analisis statistik dilakukan serta asosiasi diuji dengan uji Chi-Square. Data yang digunakan dalam penelitian diperoleh dari rekam medis pasien di RSUD Margono Soekardjo, Purwokerto pada bulan Januari hingga Desember 2024Hasil: Dari 582 pasien, sebanyak 245 pasien memenuhi kriteria inklusi. Karsinoma sel skuamosa (SCC) ditemukan pada 147 kasus, sedangkan adenokarsinoma (AC) pada 98 kasus. Sebagian besar pasien berusia >50 tahun dan didiagnosis pada stadium II. SCC paling banyak ditemukan pada stadium II, sementara AC didapatkan paling banyak pada stadium III. Analisis statistik menunjukkan adanya hubungan bermakna dengan korelasi lemah antara usia, stadium, dan prognosis dengan tipe histologis.Kesimpulan: Terdapat korelasi signifikan antara subtipe histologis dan usia, stadium, serta prognosis kanker serviks.Kata kunci: Kanker serviks; prognosis; subtipe histologis; stadium; usia

  • Open Access

    Normal Baby Born in Spontaneous Preterm Delivery in Patient with Pregnancy-Associated Breast Cancer: Case Report

    by Yuda Putra Disastra, Adi Setyawan Prianto, Sutrisno Sutrisno, Wiryawan Permadi

    Introduction:Breast cancer during pregnancy is rare, with 2.3 to 40 cases per 100,000 women. It is typically defined as cancer diagnosed during pregnancy or within a year post-delivery. While some argue pregnancy accelerates cancer progression, others see no effect or potential protective benefits. Treating pregnant patients requires balancing the mother's cancer stage and fetal health, as surgery and chemotherapy pose risks like teratogenesis or miscarriage. Timing therapy appropriately remains a major challenge.Case Presentation: A patient, P4A0, presented with spontaneous preterm delivery and a prior history of a total left modified radical mastectomy due to left tubular breast carcinoma (T1aN1M0). She had undergone six cycles of chemotherapy with Cyclophosphamide (876 mg/m²), Epirubicin (80 mg/m²), and 5-Fluorouracil (Lipiforin) (759 mg/m²). Despite receiving chemotherapy, the patient discovered she was pregnant at 33 weeks of gestation. She arrived at the Obstetrics and Gynecology Emergency Department of Prof. Dr. Margono Soekarjo General Hospital during the second stage of labor. A female infant was born, weighing 1950 grams and measuring 44 cm in length, with no detectable congenital anomalies. The patient experienced no complications after delivery and was discharged in stable condition.Conclusion: The main challenge is deciding when to start chemotherapy in pregnant patients, considering risks like miscarriage and teratogenic effects. More research is needed to develop safe chemotherapy guidelines that balance maternal treatment and fetal health.Bayi Normal dengan Partus Prematurus Spontan pada Ibu Hamil dengan Kanker Payudara: Sebuah Laporan KasusAbstrakPendahuluan: Kanker payudara selama kehamilan jarang terjadi, dengan 2,3 hingga 40 kasus per 100.000 wanita. Kondisi ini biasanya didefinisikan sebagai kanker yang didiagnosis selama kehamilan atau dalam satu tahun setelah melahirkan. Beberapa ahli berpendapat bahwa kehamilan dapat mempercepat perkembangan kanker, sementara yang lain berpendapat bahwa kehamilan tidak memiliki pengaruh signifikan atau bahkan memberikan manfaat perlindungan tertentu. Penanganan pasien hamil memerlukan keseimbangan antara stadium kanker ibu dan kesehatan janin, karena operasi dan kemoterapi membawa risiko seperti teratogen atau keguguran. Penentuan waktu terapi yang tepat tetap menjadi tantangan utama.Presentasi Kasus: Seorang pasien, P4A0, datang dengan persalinan prematur spontan dan riwayat sebelumnya menjalani mastektomi radikal modifikasi total di sisi kiri karena karsinoma payudara tubular kiri (T1aN1M0). Pasien telah menjalani enam siklus kemoterapi dengan Cyclophosphamide (876 mg/m²), Epirubicin (80 mg/m²), dan 5-Fluorouracil (Lipiforin) (759 mg/m²). Meskipun menjalani kemoterapi, pasien baru mengetahui bahwa dirinya hamil pada usia kehamilan 33 minggu. Pasien tiba di IGD Obstetri dan Ginekologi RSUD Prof. Dr. Margono Soekarjo dalam tahap kedua persalinan. Seorang bayi perempuan lahir dengan berat badan 1950 gr dan panjang 44 cm, tanpa kelainan bawaan yang terdeteksi. Pasien tidak mengalami komplikasi setelah persalinan dan dipulangkan dalam kondisi stabil.Kesimpulan: Tantangan utama adalah menentukan waktu yang tepat untuk memulai kemoterapi pada pasien hamil, dengan mempertimbangkan risiko seperti keguguran dan efek teratogenik. Penelitian lebih lanjut diperlukan untuk mengembangkan pedoman kemoterapi yang aman, yang dapat menyeimbangkan untuk Kesehatan ibu dan janin.Kata kunci: Kanker Payudara, Kehamilan, Kemoterapi, Teratogen


  • Open Access

    Assessing the Impact of the Zero Mother Mortality Preeclampsia Program on Maternal Mortality Rates at a Single Center in Bandung, West Java (2015-2022): A Retrospective Study

    by Adhi Pribadi, Dini Hidayat, R.M. Sonny Sasotya, Muhammad Alamsyah Aziz, Windi Nurdiawan, Akhmad Yogi Pramatirta, Amillia Siddiq, Johanes Cornelius Mose, Yudi Mulyana Hidayat, Annisa Dewi Nugrahani, et al.

    The Zero Mother Mortality Preeclampsia (ZOOM) program was adopted as an accelerated initiative to curb mortality related to hypertensive disorders in pregnancy, including preeclampsia. This single-center, retrospective study in Bandung, West Java, aims to evaluate the impact of the ZOOM program implemented from 2015 to 2022. We analyzed 19,176 childbirths and associated maternal deaths due to hypertension in pregnancy. Diagnoses were validated using blood pressure measures, lab tests including urine protein, liver function, blood profiles, platelets, X-ray, echocardiography, and COVID-19 testing. The case fatality rate (CFR) was assessed to evaluate the impact of the ZOOM program. Hypertension in pregnancy was identified in 25.1% of cases, with 9.8% and 1.4% attributed to preeclampsia and eclampsia, respectively. Maternal deaths associated with hypertension accounted for 36.6%, with the majority linked to eclampsia. Heart failure (45.5%) and Hemolysis, Elevated Liver enzymes, and Low Platelets (HELLP) syndrome (22%) were the most common complications. The CFR decreased from 61% in 2018 to 10% in 2022. The overall CFR from 2015 to 2022 was 1.3%, with the highest fatality rate observed in eclampsia cases (9.4%). However, a declining trend was seen since 2018, reaching a low of 0.2% in 2021. The implementation of the ZOOM program, which includes preeclampsia re-education, early detection, prompt intervention, protocol adjustments, and a refined referral system, led to a marked reduction in maternal deaths from hypertensive pregnancy disorders.


  • Open Access

    Laparoscopic Cystectomy of Endometrioma Outcomes on Follicle Stimulating Hormone and Anti-Müllerian Hormone Levels as Predictors of the Ovarian Reserve

    by Ruswana Anwar, Agnes Wijaya, David Halim, Kemala Isnainiasih Mantilidewi, Saskia Medinawati Soraya, Tono Djuwantono, Wiryawan Permadi, Budi Handono, Sofie Krisnadi, Jusuf Effendi, et al.

    Objectives: This study aimed to examine the effect of a laparoscopic cystectomy on ovarian reserve assessed by measuring the levels of serum follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH). Materials and Methods: This prospective, analytical study measured the changes of basal FSH and AMH in endometrioma patients undergoing laparoscopic cystectomy in Dr. Hasan Sadikin Hospital from June to August 2016. An informed written consent was obtained from all patients prior to the study. Their FSH and AMH serum levels were examined one month before and after the surgery. Results: A total of 31 patients were included in the study and divided into two groups based on two age ranges of 20-35 years (n=16) and 36-42 years (n=15). It was found that the FSH serum levels increased whereas the AMH serum levels decreased in both groups after laparoscopic cystectomy (P<0.001). Conclusions: Laparoscopic cystectomy of patients with reduced endometrioma ovarian reserve was characterized by elevation of FSH serum levels and reduction of AMH serum levels.


  • Open Access

    Female Genital Tuberculosis: Clinical Presentation, Current Diagnosis, and Treatment

    by Dian Tjahyadi, Bejo Ropii, Kevin Dominique Tjandraprawira, Ida Parwati, Tono Djuwantono, Wiryawan Permadi, Tinchiu Li

    Female genital tuberculosis is a disease caused by Mycobacterium tuberculosis infection in the female reproductive tract. The disease burden among women leads to infertility is significant, especially in developing countries. The bacteria can spread from the lung into the reproductive organ through lymphatic or hematogenous. Many patients present with atypical symptoms, which mimic other gynecological conditions. Several investigations are needed to establish the diagnosis. Almost all cases of genital TB affect the fallopian tube and cause infertility in patients and endometrial involvement. Current treatment still relies on antituberculosis therapy with a combination of tubal surgery. The present review describes the epidemiological data, clinical presentation, diagnosis, and currently available treatment to cure the disease and for in vitro fertilization.